MedApp S.A. (WSE:MDA)
Poland · Delayed Price · Currency is PLN 0.1610
+0.0010 (0.63%)
Last updated: Nov 3, 2026, 3:03 PM CET
MedApp Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6.75 | 3.82 | 7.2 | 5.74 | 6.73 | 12.71 | |
Revenue Growth | 13.01% | -47.00% | 25.55% | -14.82% | -47.02% | 110.92% |
Cost of Revenue | 2.4 | 2.56 | 1.84 | 1.6 | 1.5 | 1.85 |
Gross Profit | 4.35 | 1.26 | 5.36 | 4.14 | 5.23 | 10.86 |
Selling, General & Admin | 2.55 | 2.48 | 3.39 | 3.71 | 5.47 | 5.5 |
Other Operating Expenses | 0.4 | 0.29 | -0.09 | 1.12 | -1.51 | 0.41 |
Operating Expenses | 2.95 | 2.77 | 3.3 | 4.83 | 3.96 | 5.91 |
Operating Income | 1.4 | -1.51 | 2.06 | -0.69 | 1.28 | 4.96 |
Interest Expense | -1.03 | -1.01 | -0.14 | -0.22 | -0 | - |
Interest & Investment Income | 0 | - | 0.01 | - | - | 0.01 |
Currency Exchange Gain (Loss) | - | - | - | - | - | -0.01 |
Other Non Operating Income (Expenses) | -0 | -0 | -0 | - | -0.02 | - |
EBT Excluding Unusual Items | 0.37 | -2.53 | 1.93 | -0.91 | 1.26 | 4.95 |
Impairment of Goodwill | - | - | - | -0.37 | - | - |
Gain (Loss) on Sale of Investments | - | - | - | -1.55 | -0.06 | -0.53 |
Pretax Income | 0.37 | -2.53 | 1.93 | -2.83 | 1.2 | 4.42 |
Income Tax Expense | 0.09 | 0.07 | 0.23 | 0.3 | 0.59 | 0.3 |
Earnings From Continuing Operations | 0.28 | -2.6 | 1.7 | -3.13 | 0.61 | 4.12 |
Minority Interest in Earnings | -0.12 | -0.11 | -0.07 | -0.02 | - | - |
Net Income | 0.17 | -2.71 | 1.63 | -3.15 | 0.61 | 4.12 |
Net Income to Common | 0.17 | -2.71 | 1.63 | -3.15 | 0.61 | 4.12 |
Net Income Growth | -83.51% | - | - | - | -85.23% | 115.28% |
Shares Outstanding (Basic) | 250 | 250 | 250 | 250 | 250 | 250 |
Shares Outstanding (Diluted) | 250 | 250 | 250 | 250 | 250 | 250 |
Shares Change | - | - | - | - | 0.00% | 0.04% |
EPS (Basic) | 0.00 | -0.01 | 0.01 | -0.01 | 0.00 | 0.02 |
EPS (Diluted) | 0.00 | -0.01 | 0.01 | -0.01 | 0.00 | 0.02 |
EPS Growth | -87.82% | - | - | - | -85.44% | 115.21% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1.19 | 0.75 | 0.69 | -1.33 | -0.8 | -0.68 |
Free Cash Flow Per Share | 0.01 | 0.00 | 0.00 | -0.01 | -0.00 | -0.00 |
Gross Margin | 64.50% | 32.94% | 74.50% | 72.12% | 77.74% | 85.46% |
Operating Margin | 20.76% | -39.62% | 28.65% | -12.03% | 18.97% | 38.99% |
Profit Margin | 2.47% | -70.96% | 22.61% | -54.94% | 9.04% | 32.44% |
Free Cash Flow Margin | 17.65% | 19.63% | 9.51% | -23.12% | -11.81% | -5.33% |
EBITDA | 0.94 | -0.31 | 3.4 | 4.1 | 3.08 | 6.9 |
EBITDA Margin | 13.97% | -8.20% | 47.21% | 71.51% | 45.67% | 54.27% |
D&A For EBITDA | -0.46 | 1.2 | 1.34 | 4.79 | 1.8 | 1.94 |
EBIT | 1.4 | -1.51 | 2.06 | -0.69 | 1.28 | 4.96 |
EBIT Margin | 20.76% | -39.62% | 28.65% | -12.03% | 18.97% | 38.99% |
Effective Tax Rate | 23.51% | - | 11.88% | - | 49.21% | 6.76% |